Table 2.
Baseline N = 24 |
12 months N = 24 |
p value | |
---|---|---|---|
Weight (kg) | 132.2 ± 21.4 | 96.7 ± 12.4 | < .01 |
BMI (kg/m2) | 45.6 ± 5.9 | 33.7 ± 3.9 | < .01 |
WHR | 0.92 (0.8–1) | 0.89 (0.8–0.9) | < .01 |
ANG-2 (pg/ml) | 1.3 (0.5–1.5) | 0.5 (0.2–1.3) | < .05 |
Follistatin (pg/ml) | 0.2 (0.1–0.4) | 0.1 (0.1–0.2) | < .05 |
G-CSF (pg/ml) | 0.07 (0.05–0.08) | 0.06 (0.05–0.07) | 0.2 |
HGF (pg/ml) | 0.7 (0.3–0.8) | 0.2 (0.1–0.6) | < .01 |
PDGF-BB (pg/ml) | 3.5 (2–3.9) | 3.1 (1.5–3.4) | 0.1 |
PECAM-1 (pg/ml) | 5.5 (0.8–6.6) | 1.21 (0.7–4.7) | < .01 |
VEGF (pg/ml) | 0.3 (0.1–0.5) | 0.14 (0.1–0.38) | < .05 |
Data are presented as the means ± SDs or medians (interquartile ranges) for continuous variables. Group differences were calculated using the paired Student’s t test or Wilcoxon’s test for nonnormally distributed data. For abbreviations, see Table 1